A drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism

Elliot Imler, Jin Sang Pyon, Selina Kindelay, Meaghan Torvund, Yong Quan Zhang, Sreeganga S. Chandra, Konrad E. Zinsmaier

Research output: Contribution to journalArticle

Abstract

The autosomal dominant neuronal ceroid lipofuscinoses (NCL) CLN4 is caused by mutations in the synaptic vesicle (SV) protein CSPα. We developed animal models of CLN4 by expressing CLN4 mutant human CSPα (hCSPα) in Drosophila neurons. Similar to patients, CLN4 mutations induced excessive oligomerization of hCSPα and premature lethality in a dose-dependent manner. Instead of being localized to SVs, most CLN4 mutant hCSPα accumulated abnormally, and co-localized with ubiquitinateproteins and the prelysosomal markers HRS and LAMP1. Ultrastructural examination revealed frequent abnormal membrane structures in axons and neuronal somata. The lethality, oligomerization and prelysosomal accumulation induced by CLN4 mutations was attenuated by reducing endogenous wild type (WT) dCSP levels and enhanced by increasing WT levels. Furthermore, reducing the gene dosage of Hsc70 also attenuated CLN4 phenotypes. Taken together, we suggest that CLN4 alleles resemble dominant hypermorphic gain of function mutations that drive excessive oligomerization and impair membrane trafficking.

Original languageEnglish (US)
Article numbere46607
JournaleLife
Volume8
DOIs
StatePublished - Oct 2019

Fingerprint

Ceroid
Neuronal Ceroid-Lipofuscinoses
Oligomerization
Drosophila
Mutation
Membrane structures
Carisoprodol
Neurons
Gene Dosage
Membranes
Synaptic Vesicles
Animals
Genes
Axons
Animal Models
Alleles
Phenotype
Proteins

ASJC Scopus subject areas

  • Neuroscience(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

A drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism. / Imler, Elliot; Pyon, Jin Sang; Kindelay, Selina; Torvund, Meaghan; Zhang, Yong Quan; Chandra, Sreeganga S.; Zinsmaier, Konrad E.

In: eLife, Vol. 8, e46607, 10.2019.

Research output: Contribution to journalArticle

Imler, Elliot ; Pyon, Jin Sang ; Kindelay, Selina ; Torvund, Meaghan ; Zhang, Yong Quan ; Chandra, Sreeganga S. ; Zinsmaier, Konrad E. / A drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism. In: eLife. 2019 ; Vol. 8.
@article{5bc6d72317c5482f96258d5e43e2bf8d,
title = "A drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism",
abstract = "The autosomal dominant neuronal ceroid lipofuscinoses (NCL) CLN4 is caused by mutations in the synaptic vesicle (SV) protein CSPα. We developed animal models of CLN4 by expressing CLN4 mutant human CSPα (hCSPα) in Drosophila neurons. Similar to patients, CLN4 mutations induced excessive oligomerization of hCSPα and premature lethality in a dose-dependent manner. Instead of being localized to SVs, most CLN4 mutant hCSPα accumulated abnormally, and co-localized with ubiquitinateproteins and the prelysosomal markers HRS and LAMP1. Ultrastructural examination revealed frequent abnormal membrane structures in axons and neuronal somata. The lethality, oligomerization and prelysosomal accumulation induced by CLN4 mutations was attenuated by reducing endogenous wild type (WT) dCSP levels and enhanced by increasing WT levels. Furthermore, reducing the gene dosage of Hsc70 also attenuated CLN4 phenotypes. Taken together, we suggest that CLN4 alleles resemble dominant hypermorphic gain of function mutations that drive excessive oligomerization and impair membrane trafficking.",
author = "Elliot Imler and Pyon, {Jin Sang} and Selina Kindelay and Meaghan Torvund and Zhang, {Yong Quan} and Chandra, {Sreeganga S.} and Zinsmaier, {Konrad E.}",
year = "2019",
month = "10",
doi = "10.7554/eLife.46607",
language = "English (US)",
volume = "8",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",

}

TY - JOUR

T1 - A drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism

AU - Imler, Elliot

AU - Pyon, Jin Sang

AU - Kindelay, Selina

AU - Torvund, Meaghan

AU - Zhang, Yong Quan

AU - Chandra, Sreeganga S.

AU - Zinsmaier, Konrad E.

PY - 2019/10

Y1 - 2019/10

N2 - The autosomal dominant neuronal ceroid lipofuscinoses (NCL) CLN4 is caused by mutations in the synaptic vesicle (SV) protein CSPα. We developed animal models of CLN4 by expressing CLN4 mutant human CSPα (hCSPα) in Drosophila neurons. Similar to patients, CLN4 mutations induced excessive oligomerization of hCSPα and premature lethality in a dose-dependent manner. Instead of being localized to SVs, most CLN4 mutant hCSPα accumulated abnormally, and co-localized with ubiquitinateproteins and the prelysosomal markers HRS and LAMP1. Ultrastructural examination revealed frequent abnormal membrane structures in axons and neuronal somata. The lethality, oligomerization and prelysosomal accumulation induced by CLN4 mutations was attenuated by reducing endogenous wild type (WT) dCSP levels and enhanced by increasing WT levels. Furthermore, reducing the gene dosage of Hsc70 also attenuated CLN4 phenotypes. Taken together, we suggest that CLN4 alleles resemble dominant hypermorphic gain of function mutations that drive excessive oligomerization and impair membrane trafficking.

AB - The autosomal dominant neuronal ceroid lipofuscinoses (NCL) CLN4 is caused by mutations in the synaptic vesicle (SV) protein CSPα. We developed animal models of CLN4 by expressing CLN4 mutant human CSPα (hCSPα) in Drosophila neurons. Similar to patients, CLN4 mutations induced excessive oligomerization of hCSPα and premature lethality in a dose-dependent manner. Instead of being localized to SVs, most CLN4 mutant hCSPα accumulated abnormally, and co-localized with ubiquitinateproteins and the prelysosomal markers HRS and LAMP1. Ultrastructural examination revealed frequent abnormal membrane structures in axons and neuronal somata. The lethality, oligomerization and prelysosomal accumulation induced by CLN4 mutations was attenuated by reducing endogenous wild type (WT) dCSP levels and enhanced by increasing WT levels. Furthermore, reducing the gene dosage of Hsc70 also attenuated CLN4 phenotypes. Taken together, we suggest that CLN4 alleles resemble dominant hypermorphic gain of function mutations that drive excessive oligomerization and impair membrane trafficking.

UR - http://www.scopus.com/inward/record.url?scp=85074530171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074530171&partnerID=8YFLogxK

U2 - 10.7554/eLife.46607

DO - 10.7554/eLife.46607

M3 - Article

C2 - 31663851

AN - SCOPUS:85074530171

VL - 8

JO - eLife

JF - eLife

SN - 2050-084X

M1 - e46607

ER -